Page 37 - Sun Pharma
Sun Pharma acquires Russian company for $60 million
Sun Pharma gained ownership of 85% of Biosintez's equity stake for $26 mn; it also owned a company debt of $36 mn
 "Sun Pharma acquires Russian company for $60 million")
Sun Pharma ties up with Madhya Pradesh government to combat malaria
The funds for the same will come from the Corporate Social Responsibility funds earmarked by the company
Sun Pharma gains on strong Q2 results
The stock rallied 6% to Rs 708 on BSE in early morning trade.
 "Sun Pharma gains on strong Q2 results")
Sun Pharma profit doubles on sales growth, licensing income
Net profit rises to Rs 2,235 crore in Q2 FY 17 as against Rs 1,028 crore in same period last year
 "Sun Pharma profit doubles on sales growth, licensing income")
Sun Pharma Q2 net up over two-fold at Rs 2,235 cr
Sales in its largest market, the United States, rose 9%, while those in India rose 11% in emerging markets
 "Sun Pharma Q2 net up over two-fold at Rs 2,235 cr")
Cartelisation probe against Dr Reddy's, Sun Pharma in US
Pharma stocks tumble 4% on BSE; Sun Pharma down 7.4%, Dr Reddy's loses 5.6%
Multiple pain points for Sun Pharmaceutical
Pricing pressures in US market now aggravated by fallout of drug price rise probe
Investors in pharma shares lose Rs 30,200 crore in single day
Sun Pharma, Dr Reddy's, Jubilant Life, Strides Shasun, Aurobindo Pharma were down 5% each over possible US probe into cartelisation
 "Investors in pharma shares lose Rs 30,200 crore in single day")
Pharma stocks under pressure on US anti-trust probe
Suspense over US election result also weighs on market as stocks fall 3-7 percent
 "Pharma stocks under pressure on US anti-trust probe")
Sun Pharma launches blood pressure drugs in US
Sun Pharmaceutical Industries on Thursday said it has launched generic versions of Daiichi Sankyo medicines
 "Sun Pharma launches blood pressure drugs in US")
Sun Pharma buys eye care specialist Ocular Tech for $40m
Sun will also pay more contingent on meeting drug development and sales milestones as well as tiered royalty on sales of Seciera for the company
 "Sun Pharma buys eye care specialist Ocular Tech for $40m")
Sun Pharma completes Rs 675-crore share buyback
The comapny's stock was trading at Rs 742, down 0.66 per cent from its previous close, on BSE
Sun enters vaccine space with dengue shot
This is the second tie-up between the International Centre for Genetic Engineering and Biotechnology and Sun Pharmaceuticals
Sun Pharma, ICGEB tie up to develop dengue vaccine
Sun Pharma will fund and support further development of the vaccine
 "Sun Pharma, ICGEB tie up to develop dengue vaccine")
Sun will recall 31,762 bottles of anti-depressant
This is a class III recall initiated voluntarily by Sun
Sun Pharma recalls 31,762 bottles of antidepressant drug in US
The tablets have been manufactured by Sun Pharma at its Halol plant
 "Sun Pharma recalls 31,762 bottles of antidepressant drug in US")
Sun Pharma, Ranbaxy medical reps called for talks
The medical reps contend Sun management has been "arbitrarily" transferring them after taking control
New products, campaigns to boost Sun Pharma OTC sales
After tying up with Nykaa, pharma major plans to sell products online
 "New products, campaigns to boost Sun Pharma OTC sales")
Sun Pharma's high cash levels draw criticism
Firm says treasury team has done a commendable job
Should one participate in the Sun Pharma buyback offer?
Here is an opportunity to get a 13% return in less than a month; the trouble is that the buyback ratio isn't exciting